Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

PAVmed (PAVM) Acquisitions (2021 - 2022)

PAVmed has reported Acquisitions over the past 2 years, most recently at $1.0 million for Q3 2022.

For Q3 2022, Acquisitions rose 900.0% year-over-year to $1.0 million; the TTM value through Dec 2022 reached $3.2 million, changed N/A, while the annual FY2022 figure was $3.2 million, 42.41% up from the prior year.
Acquisitions for Q3 2022 was $1.0 million at PAVmed, down from $2.1 million in the prior quarter.
Over five years, Acquisitions peaked at $2.1 million in Q4 2021 and troughed at $100000.0 in Q3 2021.